Results 191 to 200 of about 97,265 (298)

Thyrotropin and growth promoting immunoglobulin (TGI) of FRTL-5 cells have no growth stimulating activity on human thyroid epithelial cell cultures [PDF]

, 1987
Bay, V., Dwenger, M., Engel, U., Fenzi, G. F., Ingbar, S. H., Mansky, T., Mckenzie, J. M., Pinchera, Aldo, Scriba, Peter Christian, Wenzel, B. E.   +9 more
core  

Sensory network dysregulation in type 2 diabetes: Linking olfactory, visual, and cognitive function

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1234-1246, February 2026.
Abstract Aims This study investigates the relationship between multisensory (visual, somatosensory, and olfactory) dysfunction and cognitive decline in Type 2 diabetes (T2D), with a particular focus on the mediating role of olfactory dysfunction. Methods We used resting‐state fMRI to assess seed‐based functional connectivity from the primary sensory ...
Qian Li, Xin Li, Yan Bi, Jiaming Lu, Yi Zhang, Min Wu, Xinyi Shen, Zhengyang Zhu, Xin Zhang, Yining Chao, Zhou Zhang, Wen Zhang, Bing Zhang   +12 more
wiley   +1 more source

The role of mycophenolate mofetil in the therapy of thyroid eye disease. [PDF]

Ther Adv Endocrinol Metab
Witowska A, Pawluczuk E, Szczepanek-Parulska E, Ruchala M.   +3 more
europepmc   +1 more source

Quality of life in patients with thyroid eye disease.

, 2009
Mohsen Bahmani Kashkouli, Farzad Pakdel, Arezoo Astaraki, Masih Hashemi, Yasamin Honarbakhsh, Bahareh Mirarmandehi, Sara Jam   +6 more
openalex   +1 more source

Novel inflammatory biomarkers in thyroid eye disease

, 2022
Hans Olav Ueland, Grethe Åstrøm Ueland, Kristian Løvås, Lars Ertesvåg Breivk, Alexander S. Thrane, Ann‐Elin Meling Stokland, Eyvind Rødahl, Eystein S. Husebye   +7 more
openalex   +1 more source

Safety and efficacy of the therapy with CD4 + CD25highCD127‐T regulatory cells: When paediatric patient becomes adult

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1392-1402, February 2026.
Abstract Aim CD4 + CD25highCD127‐T regulatory cells (Tregs) remain a drug candidate for immunotherapy of type 1 diabetes. We completed three trials testing Tregs in recently diagnosed type 1 diabetes children. Here, we looked for long‐term safety and efficacy aspects important in the authorisation of this therapy.
Marta Bandura, Magdalena Piotrowska‐Mieczkowska, Matylda Hennig, Mateusz Gliwiński, Anna Wołoszyn‐Durkiewicz, Julia Schoenhoff, Milena Dybowska, Anna Alska, Piotr Gutknecht, Bartosz Trzeciak, Katarzyna Stefańska, Paulina Glasner, Marcin Hellmann, Jacek Burzyński, Arkadiusz Michalak, Janusz Siebert, Dorota Iwaszkiewicz‐Grześ, Małgorzata Myśliwiec, Piotr Trzonkowski   +18 more
wiley   +1 more source

Comorbidities in People With Intellectual Disability With and Without Schizophrenia and Schizophrenia Without Intellectual Disability: A Swedish Register Study (IDcare)

Journal of Intellectual Disability Research, Volume 70, Issue 2, Page 206-217, February 2026.
ABSTRACT Background Intellectual disability (ID) and schizophrenia are known to separately carry a high risk of comorbidity of mental health and physical conditions. However, the prevalence and risk of comorbidities among people diagnosed with concurrent ID and schizophrenia have to date not been studied.
Trine Lise Bakken, Anna Axmon, Magnus Sandberg   +2 more
wiley   +1 more source

Percutaneous triamcinolone injection for upper eyelid retraction in thyroid eye disease [PDF]

Shaun R. Parsons, Ario Wilson‐Pogmore, Timothy J. Sullivan   +2 more
openalex   +1 more source

Age‐Specific Diagnostic Panorama Among People With Intellectual Disabilities in Comparison With the General Population: A Longitudinal Register Study (IDcare)

Journal of Intellectual Disability Research, Volume 70, Issue 3, Page 295-315, March 2026.
ABSTRACT Background People with intellectual disabilities (ID) are known to have a higher risk for a wide range of health conditions compared to the general population. However, there is little research comparing a more comprehensive range of diseases and conditions at different ages.
Magnus Sandberg, Jimmie Kristensson, Anna Axmon   +2 more
wiley   +1 more source

Asymmetric thyroid eye disease. [PDF]

Saudi J Ophthalmol
Rana K, Yong LSS, Garg D, Patel S, Slattery J, Davis G, Chan WO, Selva D.   +7 more
europepmc   +1 more source